Sanity Group unlocks the benefits of cannabis for health and wellbeing and makes cannabis and derived products widely accessible to consumers and patients in Europe. Scientific discoveries and their medical potential are redefining the way society, politics and the medical community think about cannabis as a plant. In the past 5 years, more progress has been made than in the 50 years before. Amidst the ongoing legalization for medical and recreational purposes in North America and all around the world, Europe is following its own path. Born out of Europe’s biggest market for Cannabis, Germany, Sanity Group specializes in Europe and its very distinct, localized markets, each with its own unique regulation, healthcare system, and needs.